NASDAQ:GALT

Galectin Therapeutics Insider Trades

$1.28

-0.07 (-5.19%)

(As of 05/18/2022 04:00 PM ET)

Add

Compare

Today's Range: $1.28
▼
$1.39
50-Day Range: $1.26
▼
$1.86
52-Week Range: $1.26
▼
$4.45

Volume: 64,835 shs
Average Volume: 113,585 shs
Market Capitalization: $75.96 million

P/E Ratio: N/A
Dividend Yield: N/A
Beta: 1.64

Current Insider Ownership Percentage: 39.40%
Number Of Insiders Buying (Last 12 Months): 3
Amount Of Insider Buying (Last 12 Months): $84.62 K
Number Of Insiders Selling (Last 12 Months): 1
Amount Of Insider Selling (Last 12 Months): $274.50 K

Insider Buying and Selling by Quarter

Get GALT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Galectin Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Galectin Therapeutics (NASDAQ:GALT) Insider Trading History

Export to Excel

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/18/2022	Kevin D Freeman	Director	Buy	5,000	$1.71	$8,550.00	60,000
4/4/2022	Richard A Jr. Zordani	Director	Buy	5,000	$1.60	$8,000.00	24,583
2/2/2022	Fund L.P. 10X	Major Shareholder	Sell	10,000	$2.10	$21,000.00
1/21/2022	Elissa J Schwartz	Director	Buy	1,000	$2.00	$2,000.00
1/19/2022	Kevin D Freeman	Director	Buy	5,000	$1.96	$9,800.00
1/14/2022	Richard A Jr. Zordani	Director	Buy	5,000	$2.02	$10,100.00
1/11/2022	Fund L.P. 10X	Major Shareholder	Sell	10,000	$2.10	$21,000.00
12/6/2021	Kevin D Freeman	Director	Buy	5,000	$2.34	$11,700.00
12/2/2021	Fund L.P. 10X	Major Shareholder	Sell	10,000	$2.37	$23,700.00
11/1/2021	Fund L.P. 10X	Major Shareholder	Sell	10,000	$3.19	$31,900.00

10/29/2021	Kevin D Freeman	Director	Buy	2,000	$3.17	$6,340.00
10/21/2021	Kevin D Freeman	Director	Buy	2,000	$3.19	$6,380.00
10/19/2021	Kevin D Freeman	Director	Buy	3,000	$3.37	$10,110.00
10/15/2021	Fund L.P. 10X	Major Shareholder	Sell	10,000	$3.37	$33,700.00
10/4/2021	Fund L.P. 10X	Major Shareholder	Sell	10,000	$3.62	$36,200.00
9/23/2021	Kevin D Freeman	Director	Buy	3,000	$3.88	$11,640.00
9/1/2021	Fund L.P. 10X	Major Shareholder	Sell	10,000	$3.91	$39,100.00
8/2/2021	Fund L.P. 10X	Major Shareholder	Sell	10,000	$3.25	$32,500.00
7/9/2021	Fund L.P. 10X	Major Shareholder	Sell	10,000	$3.54	$35,400.00
5/3/2021	Fund L.P. 10X	Major Shareholder	Sell	27,500	$3.97	$109,175.00
4/5/2021	Kevin D Freeman	Director	Buy	5,000	$2.04	$10,200.00	23,469
4/1/2021	Fund L.P. 10X	Major Shareholder	Sell	10,000	$2.16	$21,600.00
2/2/2021	Fund L.P. 10X	Major Shareholder	Sell	10,000	$2.04	$20,400.00
1/11/2021	Gilbert F Amelio	Director	Sell	60,000	$2.17	$130,200.00	60,614
10/13/2020	Fund L.P. 10X	Major Shareholder	Sell	10,000	$2.97	$29,700.00
9/4/2020	Kevin D Freeman	Director	Buy	5,000	$2.57	$12,850.00	23,469
3/19/2020	Kevin D Freeman	Director	Buy	6,000	$1.69	$10,140.00
1/17/2020	Fund L.P. 10X	Major Shareholder	Sell	10,000	$2.97	$29,700.00
11/15/2019	Kevin D Freeman	Director	Buy	3,000	$3.36	$10,080.00	23,469
10/10/2019	Fund L.P. 10X	Major Shareholder	Sell	17,000	$3.73	$63,410.00
9/6/2019	Kevin D Freeman	Director	Buy	1,290	$3.71	$4,785.90	23,469
5/31/2019	Jack W Callicutt	CFO	Buy	2,354	$4.28	$10,075.12	3,614
5/31/2019	Richard E Uihlein	Director	Buy	4,680,606	$4.28	$20,032,993.68	3,128,489
4/9/2019	Richard E Uihlein	Director	Buy	20,700	$4.82	$99,774.00	2,628,489
4/5/2019	Kevin D Freeman	Director	Buy	500	$4.73	$2,365.00	22,043
2/22/2019	Marc Rubin	Director	Sell	51,185	$6.02	$308,133.70	13,581
2/8/2019	Kevin D Freeman	Director	Buy	1,500	$4.29	$6,435.00	22,043
1/31/2019	Gilbert F Amelio	Director	Sell	30,000	$5.00	$150,000.00
1/29/2019	Richard E Uihlein	Director	Buy	51,500	$4.87	$250,805.00	2,538,289
9/25/2018	Kary Eldred	Director	Buy	2,000	$6.10	$12,200.00	41,382
9/10/2018	Gilbert S Omenn	Director	Sell	19,370	$6.02	$116,607.40	56,561
9/7/2018	Gilbert S Omenn	Director	Sell	11,000	$6.03	$66,330.00	56,561
9/4/2018	Marc Rubin	Director	Sell	11,900	$6.58	$78,302.00
8/30/2018	Marc Rubin	Director	Sell	58,100	$6.08	$353,248.00	84,581
6/25/2018	Joel Lewis	Director	Buy	1,000	$7.06	$7,060.00	51,480
6/20/2018	Jack W Callicutt	CFO	Sell	226,000	$8.61	$1,945,860.00	103,993
6/18/2018	Fund L.P. 10X	Major Shareholder	Sell	151,860	$8.61	$1,307,514.60
6/18/2018	James C Czirr	Director	Sell	60,000	$9.06	$543,600.00
6/15/2018	James C Czirr	Director	Sell	15,475	$8.47	$131,073.25
6/14/2018	Fund L.P. 10X	Major Shareholder	Sell	76,385	$8.28	$632,467.80
6/13/2018	Harold H Shlevin	COO	Sell	43,698	$7.41	$323,802.18
6/13/2018	James C Czirr	Director	Sell	208,140	$7.17	$1,492,363.80
6/13/2018	Peter G Traber	CEO	Sell	100,000	$7.51	$751,000.00	207,333
6/11/2018	Harold H Shlevin	COO	Sell	115,054	$5.84	$671,915.36	103,914
6/11/2018	Jack W Callicutt	CFO	Sell	120,000	$5.85	$702,000.00	101,260
6/8/2018	Jack W Callicutt	CFO	Sell	100,000	$5.75	$575,000.00	101,260
6/8/2018	James C Czirr	Director	Sell	110,000	$5.88	$646,800.00
6/8/2018	Peter G Traber	CEO	Sell	70,000	$5.86	$410,200.00	177,333
6/7/2018	Harold H Shlevin	COO	Sell	109,969	$5.20	$571,838.80	58,094
6/5/2018	Harold H Shlevin	COO	Sell	20,831	$5.15	$107,279.65	59,414
6/4/2018	Fund L.P. 10X	Major Shareholder	Sell	50,000	$5.12	$256,000.00
6/1/2018	Harold H Shlevin	COO	Sell	119,200	$5.06	$603,152.00	103,914
5/31/2018	Jack W Callicutt	CFO	Sell	46,651	$5.00	$233,255.00	47,911
4/16/2018	Theodore Daniel Zucconi	Director	Sell	4,000	$3.58	$14,320.00	5,083
4/4/2018	Jack W Callicutt	CFO	Sell	3,349	$5.00	$16,745.00	4,609
2/1/2018	Kevin D Freeman	Director	Buy	2,000	$4.10	$8,200.00	22,043
1/26/2018	Fund L.P. 10X	Major Shareholder	Sell	244,444	$5.43	$1,327,330.92
1/25/2018	James C Czirr	Director	Sell	205,144	$5.45	$1,118,034.80
12/8/2017	Marc Rubin	Director	Buy	7,000	$1.85	$12,950.00	55,581
5/23/2017	Theodore Daniel Zucconi	Director	Buy	1,000	$2.27	$2,270.00	1,083
1/5/2016	Arthur Greenberg	Director	Buy	1,666	$1.72	$2,865.52	109,445
8/12/2015	Peter G Traber	CEO	Buy	2,000	$2.00	$4,000.00
6/1/2015	Kevin D Freeman	Director	Buy	2,083	$2.70	$5,624.10
6/1/2015	Peter G Traber	CEO	Buy	4,000	$2.53	$10,120.00
8/19/2014	Arthur Greenberg	Director	Buy	1,000	$4.56	$4,560.00
8/15/2014	Kevin D Freeman	Director	Buy	1,000	$4.70	$4,700.00
8/14/2014	Jack W Callicutt	CFO	Buy	1,000	$4.55	$4,550.00
8/14/2014	Peter G Traber	CEO	Buy	4,000	$4.46	$17,840.00
8/13/2014	Peter G Traber	CEO	Buy	1,000	$4.42	$4,420.00
4/11/2014	Steven Prelack	Director	Sell	6,000	$11.84	$71,040.00
1/13/2014	James C Czirr	Chairman	Sell	100,000	$14.84	$1,484,000.00
12/4/2013	Marc Rubin	Director	Buy	3,000	$8.69	$26,070.00
11/19/2013	Arthur Greenberg	Director	Buy	2,000	$6.55	$13,100.00
11/19/2013	Peter G Traber	CEO	Buy	1,000	$5.53	$5,530.00
11/18/2013	Peter G Traber	CEO	Buy	1,000	$5.80	$5,800.00
11/15/2013	James C Czirr	Chairman	Buy	1,000	$6.90	$6,900.00
6/3/2013	John F Mauldin	Director	Buy	1,176	$4.21	$4,950.96
5/28/2013	Kevin D Freeman	Director	Buy	1,000	$4.21	$4,210.00
10/12/2012	Peter G Traber	CEO	Buy	2,500	$2.11	$5,275.00
10/9/2012	Peter G Traber	CEO	Buy	2,500	$2.00	$5,000.00
10/8/2012	Peter G Traber	CEO	Buy	5,000	$2.07	$10,350.00

(Data available from 1/1/2013 forward)

Galectin Therapeutics (NASDAQ:GALT) Insider Trade Frequently Asked Questions

Who is on Galectin Therapeutics's Insider Roster?: The list of insiders at Galectin Therapeutics includes Elissa J Schwartz, Fund L.P. 10X, Gilbert F Amelio, Jack W Callicutt, Kevin D Freeman, Richard A Jr. Zordani, and Richard E Uihlein. Learn more on insiders at GALT.
What percentage of Galectin Therapeutics stock is owned by insiders?: 39.40% of Galectin Therapeutics stock is owned by insiders. Learn more on GALT's insider holdings.
Which Galectin Therapeutics insiders have been buying company stock?: The following insiders have purchased Galectin Therapeutics stock in the last 24 months: Elissa J Schwartz ($2,000.00), Kevin D Freeman ($87,570.00), and Richard A Jr. Zordani ($18,100.00).

How much insider buying is happening at Galectin Therapeutics?: Insiders have purchased a total of 46,000 Galectin Therapeutics shares in the last 24 months for a total of $107,670.00 bought.
Which Galectin Therapeutics insiders have been selling company stock?: The following insiders have sold Galectin Therapeutics stock in the last 24 months: Fund L.P. 10X ($455,375.00), and Gilbert F Amelio ($130,200.00).
How much insider selling is happening at Galectin Therapeutics?: Insiders have sold a total of 207,500 Galectin Therapeutics shares in the last 24 months for a total of $585,575.00 sold.

This page was last updated on 5/18/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources